Keros Therapeutics, Inc. (KROS)

Keros Therapeutics Stock Forecast

Stock Price Forecast

The 10 analysts that cover Keros Therapeutics stock have a consensus rating of "Buy" and an average price target of $22.2, which forecasts a 5.56% increase in the stock price over the next year. The lowest target is $15 and the highest is $27.

Price Target: $22.2 (+5.56%)

Analyst Consensus: Buy

Target	Low	Average	Median	High
Price	$15	$22.2	$25	$27
Change	-28.67%	+5.56%	+18.88%	+28.39%

* Price targets were last updated on Nov 28, 2025.

Analyst Ratings

The average analyst rating for Keros Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating	Jul '25	Aug '25	Sep '25	Oct '25	Nov '25	Dec '25
Strong Buy	2	3	3	3	3	3
Buy	3	3	3	3	5	5
Hold	8	8	8	8	7	4
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	13	14	14	14	15	12

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Jason Zemansky B of A Securities	B of A Securities	Hold Maintains $18 → $19	Hold	Maintains	$18 → $19	-9.65%	Nov 28, 2025
Andreas Argyrides Oppenheimer	Oppenheimer	Buy Reiterates $23 → $27	Buy	Reiterates	$23 → $27	+28.39%	Nov 12, 2025
Benjamin Burnett Wells Fargo	Wells Fargo	Buy Maintains $26 → $23	Buy	Maintains	$26 → $23	+9.37%	Nov 11, 2025
Yun Zhong Wedbush	Wedbush	Hold Maintains $15 → $16	Hold	Maintains	$15 → $16	-23.92%	Nov 6, 2025
Andres Y. Maldonado HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Maintains $25 → $20	Strong Buy	Maintains	$25 → $20	-4.90%	Aug 8, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

249.38M

Increased by 6,924.79%

from 3.55M

Revenue Next Year

14.32M

Decreased by -94.26%

from 249.38M

EPS This Year

2.19

from -5.00

EPS Next Year

-3.30

from 2.19

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026
Revenue	-	20.10M	-	151.00K	3.55M	249.38M	14.32M
Revenue Growth	-	-	-	-	2,250.99%	6,924.79%	-94.26%
EPS	-2.93	-2.52	-4.15	-5.20	-5.00	2.19	-3.30
EPS Growth	-	-	-	-	-	-	-
Forward PE	-	-	-	-	-	9.61	-
No. Analysts	-	-	-	-	-	12	12

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027	2028	2029	2030
High	266.4M	60.2M
Avg	249.4M	14.3M
Low	229.6M	n/a

Revenue Growth

Revenue Growth	2025	2026	2027	2028	2029	2030
High	7,403.1%	-75.9%
Avg	6,924.8%	-94.3%
Low	6,366.8%	-

EPS Forecast

EPS	2025	2026	2027	2028	2029	2030
High	2.81	-0.78
Avg	2.19	-3.30
Low	1.06	-4.82

EPS Growth

EPS Growth	2025	2026	2027	2028	2029	2030
High	-	-
Avg	-	-
Low	-	-

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.